Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Diabetes. May 15, 2017; 8(5): 202-212
Published online May 15, 2017. doi: 10.4239/wjd.v8.i5.202
Table 4 Anthropometric measures, blood pressure, biochemistry and vascular measurements at baseline and follow-up
Baseline3 moP value for change
Weight (kg)96.2 ± 20.695.9 ± 20.60.40
Peripheral systolic blood pressure (kPa)16.9 ± 2.016.9 ± 1.90.75
Peripheral diastolic blood pressure (kPa)9.4 ± 1.39.4 ± 1.30.69
Peripheral mean arterial pressure (kPa)12 ± 1.312 ± 1.30.69
Peripheral pulse pressure (kPa)7.4 ± 1.37.4 ± 1.70.93
Central systolic blood pressure (kPa)16.8 ± 1.316.1 ± 1.90.004
Central diastolic blood pressure (kPa)10.9 ± 1.310.5 ± 1.20.002
Central mean arterial pressure (kPa)13.2 ± 1.512.8 ± 1.30.002
Central pulse pressure (kPa)5.9 ± 1.75.8 ± 1.70.09
Central augmented pressure (kPa)1.2 ± 0.61.1 ± 0.80.07
Augmentation index (%)19 ± 721 ± 120.005
cfPWV (m/s)9.4 ± 1.79.4 ± 1.80.63
Pulse transit time (m/s)60 ± 1060 ± 90.95
CCA-IMT (mm)0.72 ± 0.120.71 ± 0.1210.002
Total cholesterol (mmol/L)3.7 ± 1.03.7 ± 1.00.59
HDL cholesterol (mmol/L)1.2 ± 0.31.2 ± 0.30.54
LDL cholesterol (mmol/L)2.0 ± 0.82.0 ± 0.70.40
Triglycerides (mmol/L)1.1 ± 0.91.1 ± 0.90.53
Glucose (mmol/L)7.3 ± 2.97.3 ± 2.70.95
High sensitivity C reactive protein (mg/L)2.5 ± 2.42.4 ± 2.40.80